These observations indicate that multiple molecular and cellular mechanisms underlie the phenotype associated with disruption of KSR2 in humans, which is characterized by hyperphagia, low basal metabolic rate, obesity, and severe insulin resistance. This evidence concerns the gene KSR2 and obesity due to melanocortin 4 receptor deficiency.